Retina Group of New England - New London — Waterford, Connecticut

Retina Group of New England - New London is a clinical research site located in Waterford, Connecticut, United States 06835.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Retina Group of New England - New London has participated in 1 clinical trials.

Therapeutic areas: Geographic Atrophy Secondary to Age-related Macular Degeneration.

Sponsors: Apellis Pharmaceuticals, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Retina Group of New England - New London?

Retina Group of New England - New London has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Retina Group of New England - New London conducted?

Retina Group of New England - New London has 1 clinical trials on record. Their work covers Geographic Atrophy Secondary to Age-related Macular Degeneration.

Is Retina Group of New England - New London accredited by Crixeo Health?

Retina Group of New England - New London has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Retina Group of New England - New London?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.